SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-000349
Filing Date
2024-01-18
Accepted
2024-01-18 08:20:10
Documents
13
Period of Report
2024-01-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enfn-20240118x8k.htm   iXBRL 8-K 45545
2 EX-99.1 enfn-20240118xex99d1.htm EX-99.1 12437
  Complete submission text file 0001558370-24-000349.txt   187620

Data Files

Seq Description Document Type Size
3 EX-101.SCH enfn-20240118.xsd EX-101.SCH 3120
4 EX-101.LAB enfn-20240118_lab.xml EX-101.LAB 16578
5 EX-101.PRE enfn-20240118_pre.xml EX-101.PRE 10711
7 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20240118x8k_htm.xml XML 5062
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 24540162
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)